Zoetis (ZTS) stock closes higher, outperforms S&P 500, with analysts expecting positive earnings

From Nasdaq: 2025-03-07 18:15:10

Zoetis (ZTS) closed at $170.37, up 1.87% and outpacing the S&P 500. Shares decreased 3.95% in the last month. Analysts expect EPS of $1.41 and revenue of $2.2 billion. The Zacks Rank system rates Zoetis as a Hold. The stock is trading at a premium in the Medical – Drugs industry.

Investors should monitor Zoetis for any analyst revisions. The company is expected to report earnings of $6.12 per share and revenue of $9.31 billion for the year. Zoetis has a Forward P/E ratio of 27.35 and a PEG ratio of 2.93. The Medical – Drugs industry holds an average PEG ratio of 1.06.

Stay updated on Zoetis and other stock metrics on Zacks.com. Get early access to the Zacks Top 10 Stocks for 2025, handpicked for potential growth. The portfolio has outperformed the S&P 500. Download the 7 Best Stocks for the Next 30 Days for free. Visit Zacks Investment Research for more information.



Read more at Nasdaq: Zoetis (ZTS) Laps the Stock Market: Here’s Why